Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD)

NCT01707225 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Bleeding

Interventions

DRUG: Octreotide LAR Depot

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]
[object Object]